DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 157 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q2 2020. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $7,711,562 | +382.9% | 686,693 | +433.6% | 0.00% | – |
| Q1 2024 | $1,597,055 | +315.0% | 128,691 | +367.5% | 0.00% | – |
| Q4 2023 | $384,842 | +117.8% | 27,528 | +130.1% | 0.00% | – |
| Q3 2023 | $176,664 | -90.6% | 11,961 | -91.8% | 0.00% | -100.0% |
| Q2 2023 | $1,884,253 | +41.1% | 145,840 | +7.1% | 0.00% | 0.0% |
| Q1 2023 | $1,335,759 | +51.2% | 136,163 | +64.0% | 0.00% | – |
| Q4 2022 | $883,376 | -28.0% | 83,024 | -29.3% | 0.00% | -100.0% |
| Q3 2022 | $1,227,000 | -32.9% | 117,513 | -19.1% | 0.00% | 0.0% |
| Q2 2022 | $1,829,000 | -55.0% | 145,277 | -61.3% | 0.00% | 0.0% |
| Q1 2022 | $4,067,000 | -66.7% | 375,201 | -56.8% | 0.00% | -75.0% |
| Q4 2021 | $12,211,000 | -49.4% | 867,805 | -31.0% | 0.00% | -50.0% |
| Q3 2021 | $24,154,000 | +376.3% | 1,257,374 | +144.2% | 0.01% | +166.7% |
| Q2 2021 | $5,071,000 | -11.7% | 514,794 | -11.9% | 0.00% | 0.0% |
| Q1 2021 | $5,745,000 | +414.8% | 584,408 | +132.8% | 0.00% | – |
| Q4 2020 | $1,116,000 | -25.9% | 251,001 | -28.1% | 0.00% | – |
| Q3 2020 | $1,506,000 | -41.6% | 348,857 | +20.0% | 0.00% | -100.0% |
| Q2 2020 | $2,579,000 | +1373.7% | 290,656 | +850.4% | 0.00% | – |
| Q4 2019 | $175,000 | -12.5% | 30,584 | -38.9% | 0.00% | – |
| Q2 2019 | $200,000 | +138.1% | 50,016 | +334.3% | 0.00% | – |
| Q1 2019 | $84,000 | -35.9% | 11,517 | -19.5% | 0.00% | – |
| Q4 2018 | $131,000 | -79.7% | 14,312 | -72.6% | 0.00% | -100.0% |
| Q3 2018 | $646,000 | +221.4% | 52,163 | +295.2% | 0.00% | – |
| Q2 2018 | $201,000 | -84.1% | 13,200 | -79.3% | 0.00% | -100.0% |
| Q1 2018 | $1,266,000 | +47.9% | 63,757 | +39.2% | 0.00% | +100.0% |
| Q4 2017 | $856,000 | -36.1% | 45,800 | -26.5% | 0.00% | -50.0% |
| Q3 2017 | $1,340,000 | +306.1% | 62,308 | +82.4% | 0.00% | +300.0% |
| Q2 2017 | $330,000 | +226.7% | 34,165 | +101.0% | 0.00% | – |
| Q1 2017 | $101,000 | -79.5% | 17,000 | -86.4% | 0.00% | -100.0% |
| Q4 2016 | $493,000 | +19.7% | 124,805 | +217.6% | 0.00% | 0.0% |
| Q3 2016 | $412,000 | +102.0% | 39,300 | +270.8% | 0.00% | +100.0% |
| Q1 2016 | $204,000 | – | 10,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 10,895,773 | $47,070,000 | 4.39% |
| DC Investments Management, LLC | 196,799 | $850,000 | 0.93% |
| Chicago Capital, LLC | 3,930,524 | $16,980,000 | 0.87% |
| PFM Health Sciences, LP | 2,936,990 | $12,688,000 | 0.59% |
| Avidity Partners Management LP | 2,025,000 | $8,748,000 | 0.41% |
| Soleus Capital Management, L.P. | 167,798 | $725,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 925,534 | $3,998,000 | 0.36% |
| Haafor (Singapore) Pte. Ltd. | 27,128 | $117,000 | 0.24% |
| JACKSON SQUARE CAPITAL, LLC | 122,555 | $529,000 | 0.23% |
| Parkman Healthcare Partners LLC | 200,000 | $864,000 | 0.23% |